Pre-close Trading Statement

RNS Number : 2227P

Animalcare Group PLC

13 July 2010

 



Animalcare Group plc

Pre-Close Trading Statement

Animalcare Group plc ("the Group" or "Animalcare"), a leading supplier of veterinary medicines and other products to the veterinary and agricultural markets, issues a pre-close trading statement ahead of the publication of its results for the year to 30 June 2010. 

Group revenue for the year ended 30 June 2010 was approximately 15% more than the same period last year. As a result group earnings are expected to be slightly above market expectations.

Revenue in the Animalcare Ltd veterinary supplies business was approximately 20% ahead of the same period last year following strong performances across the product range. The new product pipeline continues to deliver. The new flavoured version of generic heart drug Benazecare, launched in the first half of the year, is performing well and two more new products were launched late in the second half of the year. The Board expects a number of new products to be launched in the coming financial year.

Revenue in the combined agriculture businesses of Ritchey, Fearing International and Travik was approximately 9% ahead of the same period last year due principally to a strong performance from Ritchey in respect of electronic sheep tags. Trading in this division remains challenging however and good progress has been made in reviewing the strategic direction for the future, the outcome of which we expect to announce at the time of the preliminary results.

It is anticipated that the announcement of preliminary results for the year ended 30 June 2010 will be made on 4 October 2010.

END

For further information:

Animalcare Group plc
James Lambert (Chairman)	01677 428 103
Stephen Wildridge (Chief Executive)	01904 487 601
Brewin Dolphin (NOMAD)
Neil Baldwin	0845 213 4726
Walbrook PR Ltd	020 7933 8787
Paul McManus	07980 541 893
	[e-mail]

 

END

 

 

TSTDMGMNKZVGGZM